- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 401/12
Total number of patents in this class: 14840
10-year publication summary
|
862
|
875
|
880
|
909
|
848
|
805
|
916
|
848
|
725
|
104
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4809 |
319 |
| Boehringer Ingelheim International GmbH | 4587 |
234 |
| Novartis AG | 10481 |
231 |
| F. Hoffmann-La Roche AG | 7881 |
183 |
| Janssen Pharmaceutica N.V. | 3322 |
181 |
| Takeda Pharmaceutical Company Limited | 2712 |
181 |
| Merck Sharp & Dohme LLC | 3748 |
156 |
| Gilead Sciences, Inc. | 2136 |
124 |
| AstraZeneca AB | 2816 |
120 |
| Pfizer Inc. | 3376 |
118 |
| Amgen Inc. | 4290 |
117 |
| Hoffmann-La Roche Inc. | 3603 |
112 |
| Bayer Pharma AG | 1036 |
112 |
| Centre National de La Recherche Scientifique | 10802 |
111 |
| Merck Patent GmbH | 5726 |
104 |
| BASF SE | 21149 |
103 |
| Genentech, Inc. | 4038 |
92 |
| Bayer Cropscience AG | 1955 |
82 |
| Epizyme, Inc. | 366 |
81 |
| The Regents of the University of California | 20366 |
76 |
| Other owners | 12003 |